The estimated Net Worth of Anthony C Hooper is at least $2.07 Million dollars as of 28 February 2022. Mr. Hooper owns over 40,000 units of Mannkind Corp stock worth over $2,074,355 and over the last 16 years he sold MNKD stock worth over $0. In addition, he makes $0 as Independent Director at Mannkind Corp.
Anthony has made over 8 trades of the Mannkind Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 40,000 units of MNKD stock worth $108,400 on 28 February 2022.
The largest trade he's ever made was exercising 381,750 units of Mannkind Corp stock on 13 May 2011 worth over $10,994,400. On average, Anthony trades about 8,445 units every 65 days since 2008. As of 28 February 2022 he still owns at least 338,394 units of Mannkind Corp stock.
You can see the complete history of Mr. Hooper stock trades at the bottom of the page.
Anthony C. Hooper serves as Independent Director of the Company. Mr. Hooper served as executive vice president of Global Commercial Operations for Amgen Inc. from Oct 2011 until August 2018. During his tenure, he led the transformation of Amgen's commercial organization, placing a relentless focus on putting patients at the center of all the company's activities. Under his leadership, Amgen grew revenue by 50 percent, launched six new first-in-class medicines for serious diseases, more than doubled the global footprint by expanding into 50 new countries, and established a new biosimilars business. Prior to joining Amgen, Hooper spent more than 15 years at Bristol-Myers Squibb. His last role there was senior vice president, Global Commercial Operations and president of the company's $15 billion pharmaceutical business in the Americas, Japan and Intercontinental regions. Previously, he was assistant vice president of Global Marketing for Wyeth Laboratories and led the international marketing group for Lederle International. Mr. Hooper earned law and MBA degrees from the University of South Africa.
Anthony Hooper is 65, he's been the Independent Director of Mannkind Corp since 2020. There are 4 older and 18 younger executives at Mannkind Corp. The oldest executive at Mannkind Corp is Kent Kresa, 82, who is the Independent Chairman of the Board.
Anthony's mailing address filed with the SEC is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108.
Over the last 20 years, insiders at Mannkind Corp have traded over $14,187,027 worth of Mannkind Corp stock and bought 107,212,962 units worth $2,707,661,837 . The most active insiders traders include Alfred E Mann, Juergen Martens, and David Thomson. On average, Mannkind Corp executives and independent directors trade stock every 27 days with the average trade being worth of $3,220,647. The most recent stock trade was executed by Stuart A Tross on 3 September 2024, trading 25,000 units of MNKD stock currently worth $156,500.
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
Mannkind Corp executives and other stock owners filed with the SEC include: